Patents by Inventor Judith Abraham

Judith Abraham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF.sub.120 and hVEGF.sub.121
    Patent number: 5219739
    Abstract: Isolated DNA sequences, expression vectors and transformant cells are provided which allow for the large scale production of vascular endothelial cell growth factor. The vascular endothelial cell growth factor is useful in the treatment of wounds in which neovascularization or reendothelialization is required for healing.
    Type: Grant
    Filed: July 27, 1990
    Date of Patent: June 15, 1993
    Assignee: Scios Nova Inc.
    Inventors: Edmund G. Tischer, Judith A. Abraham, John C. Fiddes, Richard L. Mitchell
  • Production of vascular endothelial cell growth factor
    Patent number: 5194596
    Abstract: There is described an isolated vascular endothelial cell growth factor selected from the group consisting of bovine vascular endothelial cell growth factor of 120 amino acids and human vascular endothelial cell growth factor of 121 amino acids. The vascular endothelial cell growth factor is useful in the treatment of wounds in which neovascularization or reendothelialization is required for healing.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: March 16, 1993
    Assignee: California Biotechnology Inc.
    Inventors: Edmund G. Tischer, Judith A. Abraham, John C. Fiddes, Richard L. Mitchell
  • High level expression of basic fibroblast growth factor having a homogeneous N-terminus
    Patent number: 5143829
    Abstract: DNA sequences are provided which encode a form of basic fibroblast growth factor lacking one of the alanine residues immediately following the N-terminal methionine residue of the primary translation product. The DNA sequences can be expressed to produce basic fibroblast growth factor having a homogeneous N-terminus.
    Type: Grant
    Filed: March 29, 1990
    Date of Patent: September 1, 1992
    Assignee: California Biotechnology Inc.
    Inventors: Stewart A. Thompson, Judith A. Abraham